{"gao_id": "GAO-08-835", "published": "2008-07-28T13:00:00Z", "released": "2008-07-28T09:00:00Z", "summary": "", "title": "Prescription Drugs: FDA's Oversight of the Promotion of Drugs for Off-Label Uses", "topics": ["Health information architecture", "Marketing", "Investigations by federal agencies", "Public health", "Prescription drugs", "Regulatory agencies", "Law enforcement", "Labeling law", "Pharmaceutical industry", "Federal regulations", "Food and drug legislation", "Risk management", "Advertising", "Health Care", "Consumer protection", "Food and drug law", "Sales promotion", "Materials research", "Health policy", "Safety"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-08-835", "versions": [{"title": "Highlights", "url": "https://www.gao.gov/assets/gao-08-835-highlights.pdf"}, {"title": "Full Report (46 pages)", "url": "https://www.gao.gov/assets/gao-08-835.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/a278836.html"}]}